Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:21 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Galen, your personal health companion Galen, your personal health companion Galen — A Note to Our Community Thank you
Raised $500K across 1 funding round. Latest: $500K Pre-seed (May 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (May 2025). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
Spring 2025 batch; personal AI healthcare agent unifying records and wearables.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:21 PM · confidence 88%high quality
wikipedia · Mon, Jun 29, 03:06 AM · confidence 50%medium quality
wikipedia · Mon, Jun 29, 03:06 AM · confidence 50%medium quality
Newest first · 6 event(s)
Community note: Galen AI is joining Oura.
Spring 2025 batch; personal AI healthcare agent unifying records and wearables.
Source: Homepage
Galen, your personal health companion Galen — A Note to Our Community Thank you. We're excited to share that Galen AI is joining Oura. We started Galen with a simple belief: that every person deserves to feel empowered to take control of their own health, to…
Oura acquires Galen to integrate clinical records with ring biometrics.
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Community note: Galen AI is joining Oura.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Galen, your personal health companion Galen — A Note to Our Community Thank you. We're excited to share that Galen AI is joining Oura. We started Galen with a simple belief: that every person deserves to feel empowered to take control of their own health, to…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗3 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Oura acquires Galen to integrate clinical records with ring biometrics.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Spring 2025 batch; personal AI healthcare agent unifying records and wearables.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.